- Scannexus, world-leading Ultra High-Field MRI facility based in Maastricht Netherlands, incorporates AMRA into service offering for researchers
- AMRA partners with Scannexus, thus strengthening academic relationships and clinical research opportunities in Europe
- Precise measurement of fat and muscle tissue highly valuable to researchers focusing upon metabolic disease, such as obesity and diabetes
Sweden, October , 2017: AMRA, the international leader in body composition analysis, today announced a partnership with Scannexus, a world-leading Ultra High-Field MRI scanner facility located at the Brightlands Maastricht Health Campus. The partnership was confirmed with official signatures of the collaboration agreement and a full-day AMRA introduction seminar to the Brightlands Maastricht Health Community.
Together, Scannexus and AMRA offer something new to the research community: the ability to translate a 6-minute whole body MRI scan into precise, 3D-volumetric fat and muscle measurements using scanners at Scannexus. This is good news for researchers in the Netherlands, including Maastricht and surrounding clinical research centers, as AMRA® Profiler Researcher makes it possible to understand metabolic diseases, such as obesity and diabetes.
Ultra-High-MR imaging provides new levels of insights into human anatomy and function, opening up a range of possibilities with implications for medical diagnosis and treatment. Using AMRA’s tool, AMRA® Profiler Research, researchers can now quantitatively measure fat and muscle tissue content using the same MRI scanners. Scannexus is the perfect partner for this, as the company has three ultra-high MRI scanners used intensively for research.
AMRA CEO, Tommy Johansson, came to Maastricht to announce the partnership at a seminar, “The collaboration with Scannexus will bring AMRA, a research-based company, closer to the Center of Excellence in Human Biology, NUTRIM and other clinics at Maastricht UMC+ in the Netherlands. This will add to the understanding of body composition and risk profiling of metabolic diseases.”
Scannexus CEO, Albert Scherpbier, responded that the bundling of strengths will allow them to open up a new market, “The partnership with AMRA makes it possible to get scan results produced at Scannexus and Maastricht UMC+ to researchers much faster. Researchers now have one point of contact for support with their research.”
AMRA is an international digital health company and the first in the world to transform images from a 6-minute whole body MRI scan into precise, 3D-volumetric fat and muscle measurements. AMRA’s cloud-based analysis service – AMRA® Profiler Research – offers automated insights that have far-reaching implications for the pharma industry, academic R&D and, soon, clinical practice.
Headquartered in Sweden, AMRA was founded in 2010 as a spin-off of the Center for Medical Image Science and Visualization (CMIV), the Department of Biomedical Engineering (IMT) and the Department of Medicine and Health (IMH) at Linköping University, Sweden. For more information, visit: www.amra.se
Scannexus is an Internationally focused imaging center with state of the art Ultra High-Field Imaging infrastructure and Data analysis. Scannexus offers a unique combination of services and technologies. Access to world-leading Ultra High-Field MRI scanners (3T, 7T, 9.4T) is combined with dedicated customer-focused operational support and the expertise of our clinical and technical networks.
Scannexus facilitates the development of projects, provides a one-stop-shop for contractual issues, and brings focus on project delivery. In addition, there is the ability to follow advanced level training in the principles and applications of MRI.
About Brightlands Maastricht Health Campus
Brightlands Maastricht Health Campus supervises the entire process involved in the development of innovations related to health and life sciences (valorisation) for scientists, researchers and students. Excellent facilities for imaging equipment contribute to the Campus position as the ideal location for building ecosystems involving imaging, regenerative medicine and innovative diagnostics. The Brightlands Maastricht Health Campus sets itself apart by offering the complete innovation chain: fundamental and applied research, equipment, the clinic and the cross-over possibilities with the other Brightlands campuses.